Haberkorn U - Search Results

1

Pharmacokinetic properties of peptidic radiopharmaceuticals: reduced uptake of (EH)3-conjugates in important organs.

Eder M, Löhr T, Bauder-Wüst U, Reber M, Mier W, Schäfer M, Haberkorn U, Eisenhut M. Eder M, et al. Among authors: haberkorn u. J Nucl Med. 2013 Aug;54(8):1327-30. doi: 10.2967/jnumed.112.114512. Epub 2013 Jun 26. J Nucl Med. 2013. PMID: 23804326 Free article.

2

Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy.

Haberkorn U, Reinhardt M, Strauss LG, Oberdorfer F, Berger MR, Altmann A, Wallich R, Dimitrakopoulou A, van Kaick G. Haberkorn U, et al. J Nucl Med. 1992 Nov;33(11):1981-7. J Nucl Med. 1992. PMID: 1432159 Free article.

3

Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine.

Haberkorn U, Morr I, Oberdorfer F, Bellemann ME, Blatter J, Altmann A, Kahn B, van Kaick G. Haberkorn U, et al. J Nucl Med. 1994 Nov;35(11):1842-50. J Nucl Med. 1994. PMID: 7965167 Free article.

4

Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.

Haberkorn U, Oberdorfer F, Gebert J, Morr I, Haack K, Weber K, Lindauer M, van Kaick G, Schackert HK. Haberkorn U, et al. J Nucl Med. 1996 Jan;37(1):87-94. J Nucl Med. 1996. PMID: 8544010 Free article.

5

Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates.

Haberkorn U, Altmann A, Morr I, Knopf KW, Germann C, Haeckel R, Oberdorfer F, van Kaick G. Haberkorn U, et al. J Nucl Med. 1997 Feb;38(2):287-94. J Nucl Med. 1997. PMID: 9025757 Free article.

6

Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir.

Haberkorn U, Altmann A, Morr I, Germann C, Oberdorfer F, van Kaick G. Haberkorn U, et al. J Nucl Med. 1997 Jul;38(7):1048-54. J Nucl Med. 1997. PMID: 9225789 Free article.

7

PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine.

Haberkorn U, Bellemann ME, Altmann A, Gerlach L, Morr I, Oberdorfer F, Brix G, Doll J, Blatter J, van Kaick G. Haberkorn U, et al. J Nucl Med. 1997 Aug;38(8):1215-21. J Nucl Med. 1997. PMID: 9255154 Free article.

8

Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization.

Eisenhut M, Hull WE, Mohammed A, Mier W, Lay D, Just W, Gorgas K, Lehmann WD, Haberkorn U. Eisenhut M, et al. Among authors: haberkorn u. J Med Chem. 2000 Oct 19;43(21):3913-22. doi: 10.1021/jm991079p. J Med Chem. 2000. PMID: 11052796

9

Preparation and evaluation of tumor-targeting peptide-oligonucleotide conjugates.

Mier W, Eritja R, Mohammed A, Haberkorn U, Eisenhut M. Mier W, et al. Among authors: haberkorn u. Bioconjug Chem. 2000 Nov-Dec;11(6):855-60. doi: 10.1021/bc000041k. Bioconjug Chem. 2000. PMID: 11087334

10

[123I]VIP receptor scintigraphy in patients with pancreatic adenocarcinomas.

Eisenhut M, Haberkorn U. Eisenhut M, et al. Among authors: haberkorn u. Eur J Nucl Med. 2000 Nov;27(11):1589-90. doi: 10.1007/s002590000353. Eur J Nucl Med. 2000. PMID: 11105813 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters